BIDMC Marks International Day of Women and Girls in Science – Newswise

MEDIA CONTACT

Available for logged-in reporters only

Newswise February 11 isInternational Day of Women and Girls in Science, designated by the United Nations Educational, Scientific and Cultural Organization (UNESCO) and UN-Women to promote the critical role women and girls play in science and technology communities.

BIDMC has a long history of women researchers in medicine and science. Below is a brief list of only a few of our distinguished women leaders.

Ayesha Abdeen, MD, is an orthopaedic surgeon who specializes in hip and knee replacement surgery. Shes an expert in minimally invasive surgical techniques, focusing her research on improving patient outcomes and innovative technologies. As an Assistant Professor of Orthopaedic Surgery at Harvard Medical School, shes also helping to train the next generation of surgeons.

Stephanie Buss, MD, is a cognitive neurologist who specializes in treating patients with dementia and Alzheimers disease. Her research interests include neural plasticity and non-invasive brain stimulation, and she is an Instructor in Neurology at Harvard Medical School.

Alexa B. Kimball, MD, MPH, is a dermatologist and also serves as President and CEO of Harvard Medical Faculty Physicians (HMFP) at BIDMC. A Professor of Dermatology at Harvard Medical School, Dr. Kimball is an international expert on psoriasis andhidradenitis suppurativa, and has published more than 300 peer-reviewed scientific papers.

Anica Law, MD, is a pulmonary and critical care specialist who also conducts research in BIDMCs Center for Healthcare Delivery Science. Her work focuses on improving patient outcomes in critical care, including a close look atICU nurse staffing ratios. Dr. Law is an Instructor in Medicine at Harvard Medical School.

Marsha Maurer, RN, DNP, is the Chief Nursing Officer at BIDMC and has been a leader in healthcare for more than 30 years. She completed her Doctor of Nursing Practice degree from Simmons University and continues to build a strong vision for nursing and advanced clinical care through practice research and innovation.

Rose Molina, MD, MPH, is an obstetrician-gynecologist who treats patients atThe Dimock Centerin addition to BIDMC. She is an Assistant Professor of Obstetrics, Gynecology and Reproductive Biology at Harvard Medical School and is working to ensure every personregardless of race, ethnicity, immigration status or other social factorreceives appropriate, safe and respectful care during pregnancy and childbirth.

Mary Rice, MD, is a pulmonary and critical care physician at BIDMC. As a prominent clinician-scientist focused on the study of environmental risk factors for asthma and COPD, Dr. Rice has made recentheadlinesfor her work raising awareness of the health effects of air pollution and climate change. She is an Assistant Professor of Medicine at Harvard Medical School.

Jacalyn Rosenblatt, MD, is the Associate Chief of the Division of Hematology/Hematological Malignancies and Deputy Director of the Cancer Immunotherapy Institute at BIDMC. She cares for patients with blood cancers such as multiple myeloma and leukemia, and is developing groundbreaking treatments, including personalized vaccines that use the bodys own immune system to fight cancer. Dr. Rosenblatt is an Associate Professor of Medicine at Harvard Medical School.

Andrea Steely, MD, is a cardiothoracic surgery fellow at BIDMC and a past recipient of the Thoracic Surgery FoundationsInternational Medical Volunteer Scholarship. She has traveled to Rwanda twice where rheumatic heart disease is rampant, yet there are no cardiac surgeons in the country. This fall, Dr. Steely will join a practice in Los Angeles where she will be the first woman in the cardiac surgery practice group.

Kathryn Stephenson, MD, MPH, is an immunologist and infectious disease specialist who conducts research in the Center for Virology and Vaccine Research (CVVR) at BIDMC. In addition to treating patients, she leads a research team that is developing and testing new medications to prevent and treat HIV and other infectious diseases. She serves as Director of the Clinical Trials Unit for CVVR and is an Assistant Professor of Medicine at Harvard Medical School.

Gyongyi Szabo, MD, PhD, Hon. ScD, is the Chief Academic Officer of BIDMC andBeth Israel Lahey Health(BILH). She oversees BILHs robust research and education programs, and the Technology Venture Office, supporting a broad range of basic, translational and clinical research priorities. Dr. Szabo is a physician-scientist and a leader in the field of liver immunology, with a particular focus on alcoholic hepatitis, non-alcoholic fatty liver disease and viral hepatitis.

About Beth Israel Deaconess Medical Center

Beth Israel Deaconess Medical Center is a patient care, teaching and research affiliate of Harvard Medical School and consistently ranks as a national leader among independent hospitals in National Institutes of Health funding.

BIDMC is in the community with Beth Israel Deaconess Hospital-Milton, Beth Israel Deaconess Hospital-Needham, Beth Israel Deaconess Hospital-Plymouth, Anna Jaques Hospital, Cambridge Health Alliance, Lawrence General Hospital, Signature Healthcare, Beth Israel Deaconess HealthCare, Community Care Alliance and Atrius Health. BIDMC is also clinically affiliated with the Joslin Diabetes Center and Hebrew Rehabilitation Center and is a research partner of Dana-Farber/Harvard Cancer Center and the Jackson Laboratory. BIDMC is the official hospital of the Boston Red Sox. For more information, visitwww.bidmc.org.

BIDMC is part of Beth Israel Lahey Health, a new health care system that brings together academic medical centers and teaching hospitals, community and specialty hospitals, more than 4,000 physicians and 35,000 employees in a shared mission to expand access to great care and advance the science and practice of medicine through groundbreaking research and education.

Read this article:
BIDMC Marks International Day of Women and Girls in Science - Newswise